Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on R 2 Hydroxy Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102548958A reveals a safer, high-yield synthesis for anticancer tricyclic derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101891647A details a novel Ubenimex preparation using L-lysine resolution and EDCI/HOAt coupling, ensuring >99.5% purity and robust supply chain reliability.
Solve high-cost, low-yield issues in salicylic acid synthesis. Our CDMO expertise enables scalable, eco-friendly production with >90% yield and minimal purification steps.